OFFICIAL LEGAL TITLE
No Handouts for Drug Advertisements Act
FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 119_S_1785.
Which chamber initiated this legislation?
This legislation was initiated in the Senate.
When did the legislative process begin?
The process officially started on 2025-05-15.
What are the main provisions?
Key points include:
- Pharmaceutical companies will lose the ability to deduct direct-to-consumer drug advertising costs from their taxes.
- This change applies to advertisements in media like television, radio, internet, direct mail, and billboards.
- Advertisements in journals and other periodicals will still be eligible for tax deductions.
- The law will apply to expenses paid or incurred after its enactment date.
What is the specific legal status?
The current status is Introduced.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Sen. Hawley, Josh [R-MO].
What is the latest detailed status?
The latest detailed status is: Introduced in Senate
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.
What is the impact of this bill?
We don't know—that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.